77 related articles for article (PubMed ID: 21721846)
1. Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral administration.
Lu TL; Sun WG; Zhao W; Chen T
Drug Dev Ind Pharm; 2011 Dec; 37(12):1473-80. PubMed ID: 21721846
[TBL] [Abstract][Full Text] [Related]
2. Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation.
Pamujula S; Graves RA; Moiseyev R; Bostanian LA; Kishore V; Mandal TK
J Pharm Pharmacol; 2008 Mar; 60(3):283-9. PubMed ID: 18284807
[TBL] [Abstract][Full Text] [Related]
3. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release microspheres of amifostine for improved radio-protection, patient compliance, and reduced side effects.
Wu HY; Hu ZH; Jin T
Drug Deliv; 2016 Nov; 23(9):3704-3711. PubMed ID: 27855533
[TBL] [Abstract][Full Text] [Related]
5. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
6. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
7. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of spray dried PLGA/amifostine nanoparticles.
Pamujula S; Graves RA; Freeman T; Srinivasan V; Bostanian LA; Kishore V; Mandal TK
J Pharm Pharmacol; 2004 Sep; 56(9):1119-25. PubMed ID: 15324480
[TBL] [Abstract][Full Text] [Related]
9. The initial release of cisplatin from poly(lactide-co-glycolide) microspheres.
Lee YS; Lowe JP; Gilby E; Perera S; Rigby SP
Int J Pharm; 2010 Jan; 383(1-2):244-54. PubMed ID: 19766179
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
12. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
Rawat A; Burgess DJ
Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
[TBL] [Abstract][Full Text] [Related]
14. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
17. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
18. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of biodegradable enteric microcapsules of amifostine for oral delivery.
A G; Ren L; Zhou Z; Lu D; Wang S
Int J Pharm; 2013 Sep; 453(2):441-7. PubMed ID: 23796837
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GRF encapsulated in PLGA microspheres in animal skeletal muscle induces body weight gain.
Zhang YL; Ren XH; Liu SC; Dai JW; Hao LL; Jiang QY
Anim Biotechnol; 2007; 18(3):163-75. PubMed ID: 17612839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]